Gilead Sciences Market Sentiment

Gilead Sciences Inc

GILDNASDAQ

$159.34

0.250.16%

Ult. Agg.: Oct 28, 1:05 PM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Dividendi Confronta Opzioni Rapporto azionario

Utili: I risultati del Q3 2026 saranno pubblicati domani gio ott 29th dopo la chiusura del mercato

Conference call: La conference call è prevista per domani alle ore 4:30 PM

Clicca per vedere il webcast

Fusioni e acquisizioni: PepStar Therapeutics Limited announced it will sell assets to Gilead Sciences (GILD) on Thursday, October 22, 2026 for $1.3B paid in cash

Gilead Sciences Market Sentiment - Benzinga

Gilead Sciences Market Sentiment

Market sentiment signals for Gilead Sciences (GILD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 1.8% short float

Options Flow▲ 0.27 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

0.27

More calls — Bullish

3,272 calls · 897 puts

Avg Consensus PT

$140

-12.3%

Highest Price Target

$180

+13.0%

Jefferies

Lowest Price Target

$80

-49.8%

Cantor Fitzgerald

Short Interest

1.8%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 20, 2026	B of A Securities	Tim Anderson—	+7.9%	$168 → $172	Maintained	Buy
Oct 8, 2026	RBC Capital	Brian Abrahams—	-20.9%	$123 → $126	Maintained	Sector Perform
Oct 8, 2026	Cantor Fitzgerald	Carter Gould—	-2.7%	$155 → $155	Maintained	Overweight
Oct 7, 2026	Truist Securities	Gregory Renza—	-0.8%	$150 → $158	Maintained	Buy
Oct 7, 2026	JP Morgan	Chris Schott—	+6.7%	$160 → $170	Maintained	Overweight
Oct 7, 2026	Morgan Stanley	Matthew Harrison—	+2.3%	$165 → $163	Maintained	Overweight
Sep 10, 2026	HSBC	Morten Herholdt—	+9.8%	$155 → $175	Maintained	Buy
Aug 5, 2026	RBC Capital	Brian Abrahams—	-22.8%	$120 → $123	Maintained	Sector Perform
Aug 5, 2026	Cantor Fitzgerald	Carter Gould—	-2.7%	$155 → $155	Maintained	Overweight
Aug 5, 2026	Needham	Joseph Stringer—	+6.7%	$170 → $170	Maintained	Buy
Jul 29, 2026	Barclays	Emily Field—	-9.0%	$155 → $145	Maintained	Equal-Weight
Jul 27, 2026	Morgan Stanley	Matthew Harrison—	+3.6%	$166 → $165	Maintained	Overweight
Jul 21, 2026	Leerink Partners	Daina Graybosch—	-20.3%	$146 → $127	Downgrade	Outperform→Market Perform
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	+4.2%	$168 → $166	Maintained	Overweight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-24.7%	$122 → $120	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-2.1%	$157 → $156	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	-2.7%	$155 → $155	Maintained	Overweight
Jul 6, 2026	HSBC	Morten Herholdt—	-2.7%	$133 → $155	Upgrade	Hold→Buy
Jun 16, 2026	Cantor Fitzgerald	Carter Gould—	-2.7%	$155 → $155	Maintained	Overweight
May 20, 2026	Maxim Group	Michael Okunewitch—	+3.6%	$165	Upgrade	Hold→Buy
May 8, 2026	Truist Securities	Gregory Renza—	-1.5%	$155 → $157	Maintained	Buy
May 8, 2026	RBC Capital	Brian Abrahams—	-23.4%	$123 → $122	Maintained	Sector Perform
Apr 13, 2026	Citigroup	Geoff Meacham—	+3.6%	$156 → $165	Maintained	Buy
Apr 10, 2026	Morgan Stanley	Matthew Harrison—	+9.8%	$171 → $175	Maintained	Overweight
Mar 10, 2026	Jefferies	Akash Tewari—	+13.0%	$180	Initiate	Buy